...
首页> 外文期刊>Journal of pharmaceutical sciences. >Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
【24h】

Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.

机译:半乳糖密度对脱唾液酸糖蛋白受体介导的半乳糖基化脂质体摄取的影响。

获取原文
获取原文并翻译 | 示例

摘要

Galactosylated (Gal) liposomes containing various molar ratios of cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)formamide (Gal-C4-Chol) as a ligand for asialoglycoprotein receptors were prepared to study the effect of the galactose content of Gal-liposomes labeled with [3H]cholesteryl hexadecyl ether on their targeted delivery to hepatocytes. The uptake characteristics of Gal-liposomes having Gal-C4-Chol of 1.0%, 2.5%, 3.5%, 5.0%, and 7.5% were evaluated. The uptake and internalization by HepG2 cells was enhanced by the addition of Gal-C4-Chol to the Gal-liposomes. In the presence of excess galactose, the uptake of Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5% was inhibited suggesting asialoglycoprotein receptor mediated uptake. After intravenous injection, Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5%, rapidly disappeared from the blood and exhibited rapid liver accumulation with up to about 80% of the dose within 10 min whereas Gal-liposomes having low Gal-C4-Chol (1.0% and 2.5%) showed a slight improvement in liver accumulation compared with bare-liposomes. Gal-liposomes with high Gal-C4-Chol are preferentially taken up by hepatocytes and the highest uptake ratio by parenchymal cells (PC) and nonparenchymal cells (NPC) (PC/NPC ratio) was observed with Gal-liposomes having of 5.0% Gal-C4-Chol. We report here that the galactose density of Gal-liposomes prepared by Gal-C4-Chol is important for both effective recognition by asialoglycoprotein receptors and cell internalization.
机译:制备了含有不同摩尔比的胆固醇5-乙酰氧基-N-(4-((1-亚氨基-2-D-硫代半乳糖基乙基)甲酰胺(Gal-C4-Chol)作为脱唾液酸糖蛋白受体配体的半乳糖基化(Gal)脂质体,研究[3H]胆固醇基十六烷基醚标记的Gal脂质体的半乳糖含量对其靶向递送至肝细胞的影响。Gal-C4-Chol为1.0%,2.5%,3.5%,5.0的Gal脂质体的吸收特性在Gal脂质体中加入Gal-C4-Chol增强了HepG2细胞的摄取和内在化;在半乳糖过量的情况下,具有Gal-C4的Gal-脂质体的摄取抑制3.5%,5.0%和7.5%的Chol,表明去唾液酸糖蛋白受体介导的摄取;静脉注射后,具有3.5%,5.0%和7.5%的Gal-C4-Chol的Gal-脂质体迅速从血液中消失并表现出快速肝脏蓄积,在10分钟内达到剂量的约80%,而Gal脂质体具有低剂量与裸脂质体相比,Gal-C4-Chol(1.0%和2.5%)显示出肝脏蓄积的轻微改善。高Gal-C4-Chol的Gal脂质体优先被肝细胞吸收,并且在含5.0%Gal的Gal脂质体中观察到最高的实质细胞(PC)和非实质细胞(NPC)吸收率(PC / NPC比)。 -C4-Chol。我们在这里报告,由Gal-C4-Chol制备的Gal脂质体的半乳糖密度对于脱唾液酸糖蛋白受体的有效识别和细胞内在化都是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号